Native Mass Spectrometry Can Effectively Predict PROTAC Efficacy

• Rebecca Beveridge,
• Dirk Kessler,
• Klaus Rumpel,
• Peter Ettmayer,
• Anton Meinhart,
• Tim Clausen

Affiliations

Rebecca Beveridge

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria

Dirk Kessler

Discovery Research, Boehringer Ingelheim Regional Center Vienna GmbH & Co KG, Vienna, Austria

Klaus Rumpel

Discovery Research, Boehringer Ingelheim Regional Center Vienna GmbH & Co KG, Vienna, Austria

Peter Ettmayer

Discovery Research, Boehringer Ingelheim Regional Center Vienna GmbH & Co KG, Vienna, Austria

Anton Meinhart

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria

Tim Clausen

Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria